U.S. stocks mixed ahead of Fed decision
FTI Consulting, Inc. (NYSE:FCN), a $5.3 billion market cap consulting firm, announced Monday that its Board of Directors has appointed Paul Linton as interim Chief Financial Officer, effective September 12, 2025. The appointment follows the previously disclosed resignation of Ajay Sabherwal as CFO. According to InvestingPro data, the company maintains strong financial health with a current ratio of 2.11, indicating robust liquidity management.
Linton, 54, will assume the interim CFO role in addition to his current position as Chief Strategy and Transformation Officer, a role he has held since joining the company in August 2014. According to the company, there have been no changes to Linton’s compensation as previously detailed in its proxy statement filed with the Securities and Exchange Commission on April 21, 2025.
The company stated that Linton was selected for the interim CFO position without any arrangements or understandings with other parties. He does not have any family relationships with directors or executive officers of FTI Consulting, nor does he have any direct or indirect material interest in transactions requiring disclosure under SEC regulations.
This information is based on a press release statement included in the company’s Form 8-K filing with the Securities and Exchange Commission.
In other recent news, FTI Consulting reported second-quarter earnings and revenue that exceeded analyst expectations. The company achieved adjusted earnings per share of $2.13, surpassing the consensus estimate of $1.90. Revenue for the quarter reached $943.7 million, which was higher than the expected $912.2 million, although it showed a slight decrease compared to the same period last year. Additionally, FTI Consulting has announced a leadership change, with Chief Financial Officer Ajay Sabherwal set to depart in September. Paul Linton, the current Chief Strategy and Transformation Officer, will step in as interim CFO. The firm is actively searching for a permanent replacement. Moreover, the company appointed Dr. Shaun Rangappa as a Senior Managing Director in its Healthcare Business Transformation practice. Dr. Rangappa will also serve as Chief Clinical Executive, bringing over 30 years of healthcare experience to the role.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.